2011
DOI: 10.1084/jem20813oia35
|View full text |Cite
|
Sign up to set email alerts
|

VPS35 haploinsufficiency increases Alzheimer's disease neuropathology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
93
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 59 publications
(96 citation statements)
references
References 1 publication
3
93
0
Order By: Relevance
“…Moreover, there is increasing realization that perturbed CSC function is linked to a number of human diseases. CSC deficiency plays a role in nonamyloidogenic versus amyloidogenic processing of amyloid precursor protein (APP) (He et al 2005;Small et al 2005;Muhammad et al 2008;Wen et al 2011;Choy et al 2012) and the pathogenesis of Alzheimer's disease (Siegenthaler and Rajendran 2012). In addition, a specific VPS35 mutation, Asp620Asn, has been linked to late-onset autosomal-dominant familial Parkinson's disease (Vilariño-Güell et al 2011;Zimprich et al 2011), the loci for human VPS26A has been genetically associated with type 2 diabetes in South Asians (Kooner et al 2011), and the endosomal transport of various pathogens (Salmonella, Herpesvirus saimiri, Coxiella burnetii, human papillomavirus, Legionella pneumophila) and toxins (Shiga toxin) is also mediated in part by the CSC Popoff et al 2007;Kingston et al 2011;Finsel et al 2013;Lipovsky et al 2013;McDonough et al 2013).…”
Section: The Diversity Of Retromer Function In Cell Function and Orgamentioning
confidence: 99%
“…Moreover, there is increasing realization that perturbed CSC function is linked to a number of human diseases. CSC deficiency plays a role in nonamyloidogenic versus amyloidogenic processing of amyloid precursor protein (APP) (He et al 2005;Small et al 2005;Muhammad et al 2008;Wen et al 2011;Choy et al 2012) and the pathogenesis of Alzheimer's disease (Siegenthaler and Rajendran 2012). In addition, a specific VPS35 mutation, Asp620Asn, has been linked to late-onset autosomal-dominant familial Parkinson's disease (Vilariño-Güell et al 2011;Zimprich et al 2011), the loci for human VPS26A has been genetically associated with type 2 diabetes in South Asians (Kooner et al 2011), and the endosomal transport of various pathogens (Salmonella, Herpesvirus saimiri, Coxiella burnetii, human papillomavirus, Legionella pneumophila) and toxins (Shiga toxin) is also mediated in part by the CSC Popoff et al 2007;Kingston et al 2011;Finsel et al 2013;Lipovsky et al 2013;McDonough et al 2013).…”
Section: The Diversity Of Retromer Function In Cell Function and Orgamentioning
confidence: 99%
“…Loss of retromer function increases amyloidogenic processing of APP, and studies of tissue from AD patients indicates that retromer expression could be downregulated in neuronal tissue, although the underlying cause is presently unknown (Small et al, 2005;Muhammad et al, 2008;Lane et al, 2010;Wen et al, 2011). It has also been shown recently that specific variants of the Snx3 and Rab7a genes are genetically linked to late-onset AD (Vardarajan et al, 2012).…”
Section: Retromer and Diseasementioning
confidence: 99%
“…Retromer and SNX27 have been shown to recycle a wide range of surface molecules, ranging from signalling receptors like the β2-adrenergic receptor (Lauffer et al, 2010) or the parathyroid hormone receptor (PTHR) (Chan et al, 2016;McGarvey et al, 2016), and nutrient transporters (Steinberg et al, 2013) to neuronal glutamate receptors (Wang et al, 2013;Loo et al, 2014;Hussain et al, 2014). Although loss of retromer as well as of the WASH complex is lethal early in embryogenesis (Wen et al, 2011;Gomez et al, 2012), loss of SNX27 is lethal shortly upon birth of genetically modified mice (Cai et al, 2011), highlighting the physiological relevance of SNX27-, retromer-and/or WASH-driven recycling processes. In this context, recent genome-wide association studies have identified mutations in the retromer subunit VPS35 as the underlying cause for late-onset hereditary Parkinsonism, with the point mutation of aspartate 620 to asparagine (D620N) being the most significant one (VilarinoGuell et al, 2011;Zimprich et al, 2011).…”
Section: Introductionmentioning
confidence: 99%